It seems as if each day we get closer and closer to having multiple Tyler’s on the market. Just today BioCorp and Roche announced that Mallya, BioCorp’s connected pen is available in France. Medtronic who acquired Companion is moving forward with their Tyler. Lilly, Novo Nordisk both have Tyler’s yet continue to move at glacial speed getting them to market. WellDoc just expanded their partnership with Dexcom, who for reasons we have yet to figure out has not entered the Tyler race yet.
Which brings us to BigFoot who besides raising boatloads of money has submitted their . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.